Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Angiotensin-converting enzyme (ACE) 2 and its product angiotensin 1–7 are thought to have effects that counteract the adverse actions of other, better-known renin–angiotensin system (RAS) components
Numerous experimental studies have suggested that ACE2 and angiotensin 1–7 have notable protective effects in the heart and blood vess...
Alternative Titles
Full title
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7097196
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7097196
Other Identifiers
ISSN
1759-5002
E-ISSN
1759-5010
DOI
10.1038/nrcardio.2014.59
